Volver a Noticias Científicas
Investigación Científica

Detalles del Artículo

Traducción pendiente · disponible próximamente

Calibration of CAR signaling promotes asymmetric cell division to direct CAR-T cell fate and antitumor potency.

¿Qué significa esto para los pacientes?

AI

Inicia sesión o regístrate para generar explicaciones con IA

Asymmetric cell division (ACD) is an evolutionarily conserved mechanism that diversifies T cell fate, yet how engineered receptor signaling regulates ACD in chimeric antigen receptor (CAR)-T cells remains unknown. Here, we show that antigen engagement induces ACD in CAR-T cells through polarized inheritance of the CAR immune synapse (CARIS), supporting the generation of progeny with divergent functional trajectories. CARhigh progeny acquires a short-lived effector-like state, whereas CARlow progeny retains memory-like features, with enhanced persistence and superior antitumor efficacy. We identify CAR signaling strength as a tunable determinant of this fate bifurcation: selective mutation of CD3ζ immunoreceptor tyrosine-based activation motifs (1XX CAR) enhances ACD.

Mechanistically, 1XX signaling promotes pre-mitotic MTOC-CARIS coupling through the PLCγ1-diacylglycerol (DAG) polarity axis, enabling asymmetric CARIS inheritance. Adoptive transfer studies further support a link between signaling-driven asymmetry, fate-determination, and therapeutic efficacy. Together, our findings reveal CAR signaling as a regulator of fate diversification through synapse-coupled asymmetric division.

Inicia sesión o regístrate para acceder al texto completo

Se abre en una nueva pestaña en la publicación original

Compartir y Discutir

Comentarios

¡Aún no hay comentarios. Sé el primero en comentar!

Enviar a mi oncólogo

Artículo: Calibration of CAR signaling promotes asymmetric cell division to direct CAR-T cell fate and antitumor potency.

Autores: Shen X, Xu X, Jiang J, Zhang S, Chen J, Chen R, Gu Y, Zhou C, Xiao G, Huang H, Huse M, Sadelain M, Zhang J, Sun J
Publicado: 2026-08-17
PMID: 42603278

Enlace: https://crcwarriors.org/article-detail.php?id=2921 | https://pubmed.ncbi.nlm.nih.gov/42603278/

¡Regístrate para usar esta función!

Crea una cuenta gratuita para enviar artículos científicos directamente a tu oncólogo y acceder a muchas más funcionalidades personalizadas.

Regístrate gratis